ConductScience.org, home

Paper8940144

Feedback mechanism of focal vascular lesion formation in transgenic apolipoprotein(a) mice.

Lawn RM and 6 others. J Biol Chem, 1996. Cited by 49 papers, by iCite.

Cite this record

ConductScience Library. Feedback mechanism of focal vascular lesion formation in transgenic apolipoprotein(a) mice. Papers, record 8940144. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8940144

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Feedback mechanism of focal vascular lesion formation in transgenic apolipoprotein(a) mice.
PubMed
Journal
J Biol Chem
PubMed
Year
1996
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
49
iCite
Relative citation ratio, by iCite
1.24
iCite
Revised in PubMed
2021-02-09
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Lawn RMR M
2Pearle ADA D
3Kunz LLL L
4Rubin EME M
5Reckless JJ
6Metcalfe JCJ C
7Grainger DJD J

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Apolipoproteins AMajor topic
Muscle, Smooth, VascularMajor topic
Transforming Growth Factor betaMajor topic
Animals
Apolipoprotein A-I
Cell Differentiation
Dietary Fats
Humans
Lipoproteins, HDL
Male
Mice
Mice, Transgenic
Microscopy, Electron
Tamoxifen

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
Wellcome TrustUnited KingdomPubMed

Source PubMed

Download CSV of grants

Cited by11

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 49 citations.

PMIDTitleJournalYearIn PapersSource
32099678Lipoprotein(a) the Insurgent: A New Insight into the Structure, Function, Metabolism, Pathogenicity, and Medications Affecting Lipoprotein(a) Molecule.J Lipids2020https://conductscience.org/library/papers/32099678PubMed
27601313Clinically used selective estrogen receptor modulators affect different steps of macrophage-specific reverse cholesterol transport.Sci Rep2016https://conductscience.org/library/papers/27601313PubMed
23581552Apolipoprotein (a) impairs endothelial progenitor cell-mediated angiogenesis.DNA Cell Biol2013https://conductscience.org/library/papers/23581552PubMed
23484137Lipoprotein(a) in cardiovascular diseases.Biomed Res Int2013https://conductscience.org/library/papers/23484137PubMed
18997104A physiological function for apolipoprotein(a): a natural regulator of the inflammatory response.Exp Biol Med (Maywood)2009https://conductscience.org/library/papers/18997104PubMed
16646981Activation of transforming growth factor-beta1 and early atherosclerosis in systemic lupus erythematosus.Arthritis Res Ther2006https://conductscience.org/library/papers/16646981PubMed
11313820Adenovirus-mediated apo(a)-antisense-RNA expression efficiently inhibits apo(a) synthesis in vitro and in vivo.Gene Ther2001https://conductscience.org/library/papers/11313820PubMed
9770530Fibrinogen deficiency reduces vascular accumulation of apolipoprotein(a) and development of atherosclerosis in apolipoprotein(a) transgenic mice.Proc Natl Acad Sci U S A1998https://conductscience.org/library/papers/9770530PubMed
9539774Low density lipoprotein receptor-negative mice expressing human apolipoprotein B-100 develop complex atherosclerotic lesions on a chow diet: no accentuation by apolipoprotein(a).Proc Natl Acad Sci U S A1998https://conductscience.org/library/papers/9539774PubMed
9294116Lipoprotein(a) vascular accumulation in mice. In vivo analysis of the role of lysine binding sites using recombinant adenovirus.J Clin Invest1997https://conductscience.org/library/papers/9294116PubMed
9239402Modification of apolipoprotein(a) lysine binding site reduces atherosclerosis in transgenic mice.J Clin Invest1997https://conductscience.org/library/papers/9239402PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
APOA1335PubTator's text mininghttps://conductscience.org/library/genes/335NCBI Gene
LPA4018PubTator's text mininghttps://conductscience.org/library/genes/4018NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/8940144

GET https://conductscience.org/api/papers/v1/8940144/authors